Search Results

You searched for : LatestMerckNews  

Merck Announces U.S. FDA Approval of VAXNEUVANCE for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older

Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus....
Jul 17

LYNPARZA (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Treatments in BRCA1/2-Mutated Advanced Prostate Cancer...
Jun 24

Merck to Participate in the Guggenheim Biopharma Strategy Series

Merck Research Laboratories, is scheduled to participate in a virtual fireside chat at the Guggenheim Biopharma Strategy Series...
Jun 19

Merck Announces Supply Agreement with U.S. Government for Molnupiravir

...
Jun 09

U.S. FDA Accepts for Priority Review the Biologics License Application for V114

Merck announced the U.S. FDA accepted for priority review a Biologics License Application for V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine, for ...
Jan 12

LYNPARZA (olaparib) Receives Three New Approvals in Japan

LYNPARZA has been approved in Japan for the treatment of three types of advanced cancer: ovarian, prostate and pancreatic cancer....
Dec 28

Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of COVID-19

...
Dec 23

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA

...
Dec 18

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA

Patients with newly diagnosed esophageal and GEJ cancer face an aggressive disease with a poor prognosis, despite the currently available treatment options...
Dec 17

KEYTRUDA Plus LENVIMA Combination Demonstrated Statistically Significant Improvement in Overall Survival

...
Dec 16

Merck Receives Positive EU CHMP Opinion for KEYTRUDA as First-Line Treatment for Metastatic Microsatellite Instability

...
Dec 11

Acquisition adds to Merck’s suite of clinical programs in response to SARS-CoV-2/COVID-19

Meaningful new therapeutic options are desperately needed for possibly millions of people around the world who will develop severe or critical COVID-19 disease...
Nov 23

Merck Submits Applications for Licensure of V114, the Company’s Investigational 15-valent Pneumococcal Conjugate Vaccine

...
Nov 23

Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for Women at High Risk for Acquiring HIV-1

Collaboration with the Bill & Melinda Gates Foundation Seeks to Bring Forward a New HIV Prevention Option with Focus on Women...
Nov 16

KEYTRUDA plus LENVIMA met the trial’s primary endpoint of progression-free survival

LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma...
Nov 10

LYNPARZA Approved in the EU for Treatment of BRCA1/2-Mutated Metastatic Castration-Resistant Prostate Cancer

Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Agent Treatments in BRCA1/2-Mutated mCRPC...
Nov 05

Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts

Merck and the MECTIZAN Donation Program, announced today a $500,000 cash donation to support NGO partners working to eliminate onchocerciasis and lymphatic filariasis...
Oct 22

Merck Announces Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine

Pneumococcal disease in adults is on the rise globally, in part driven by disease-causing serotypes not targeted by the currently available pneumococcal conjugate vaccine...
Oct 21

FDA Approves Expanded Indication for Merck’s KEYTRUDA in Adult Patients With classical Hodgkin Lymphoma (cHL)

...
Oct 15

Merck Announces Week 96 Data from Phase 2b Study Evaluating Islatravir With Doravirine for HIV-1

Merck, today announced Week 96 data from the Phase 2b trial evaluating the efficacy and safety of islatravir for HIV-1 infections...
Oct 08

Merck Animal Health Supports Rabies Elimination by 2030 on World Rabies Day

Merck Animal Health announced the launch of a global campaign to raise awareness among veterinarians, dog owners and volunteers who are committed to eliminate rabies ...
Sep 28

21 Matching result(s) found!

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024